Apollo Hospitals Plans to Partner with Other Hospitals to Grow its Transplant Programme

India Pharma Outlook Team | Monday, 24 July 2023

 India Pharma Outlook Team

Apollo Hospitals plans to have a transplant programme in all its locations along with collaborations with hospitals outside its network, as it sees rising demand from within India and overseas. Preetha Reddy, executive vice-chairperson of Apollo Hospitals said, every location Apollo is present will do kidney and liver transplant, but heart and lungs transplants will be done at its large hospitals in metro cities due to infrastructure and talent acquisition issues.

"In every location where we expand, we will be expanding the transplant program and we are also collaborating with existing hospitals and running their transplant programs," Reddy said. "We could expand (heart and lung transplants), but the cost of capital is huge," Reddy said."We have to be judicious about how much we do we are going steady," she added. Apollo does the highest number of solid organ transplants in the world per year.

The hospital chain performed 1641 transplants in 2022. So far since its inception, it has performed 18,500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants. The solid organ transplant programme is run under the brand - Apollo Transplant Institutes, which are spread across more than 24 locations, 8 of which perform liver transplants and 6 perform multi-organ transplants, offering the entire spectrum of liver, kidney, lung and heart failure.

© 2024 India Pharma Outlook. All Rights Reserved.